Abstract |
In BriefSpinal cord injury is among the most devastating neurological conditions affecting humans. The authors assessed the therapeutic efficacy of subcutaneous recombinant granulocyte colony-stimulating factor as an adjunct to classic surgical and rehabilitative treatments for subacute traumatic spinal cord injuries. This safe and noninvasive treatment may be helpful for better care and satisfaction of patients with this devastating condition throughout the world.
|
Authors | Nazi Derakhshanrad, Hooshang Saberi, Mir Saeed Yekaninejad, Mohammad Taghi Joghataei |
Journal | Journal of neurosurgery. Spine
(J Neurosurg Spine)
Vol. 30
Issue 1
Pg. 19-30
(10 12 2018)
ISSN: 1547-5646 [Electronic] United States |
PMID | 30497202
(Publication Type: Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Granulocyte Colony-Stimulating Factor
|
Topics |
- Adult
- Double-Blind Method
- Female
- Granulocyte Colony-Stimulating Factor
(therapeutic use)
- Humans
- Male
- Recovery of Function
(drug effects)
- Spinal Cord Injuries
(drug therapy, rehabilitation)
- Treatment Outcome
|